AMPK in the brain: its roles in glucose and neural metabolism
You might be wondering, How does this tie into what Im experiencing? Again, GLP-1 treatments are not prescribed specifically for menopause, but they can indirectly alleviate some symptoms associated with menopause by helping you lose weight
Tirzepatide was tested in the SURMOUNT-1 trial over 72 weeks
What it does, remarkably well, is cause rapid weight loss
Future large long-term RCTs with primary or secondary outcomes, including thyroid disorders and real-world data, are needed to elucidate the association between GLP-1 receptor agonists and the risk of various thyroid disorders, particularly thyroid cancer
This consultation is an opportunity to ask questions, express concerns, and ensure that you feel comfortable with the proposed therapy before proceeding